The latest news about Lazarex Cancer Foundation’s programs and advocacy efforts.
< Timeline >
February 28, 2024
Cancer Hope Network Announces One-On-One Peer Mentorship Collaboration with Lazarex Cancer Foundation: Cancer Hope Network and Lazarex Cancer Foundation announced today a new collaboration that will expand patient and caregiver access to psychosocial support during clinical trials through Cancer Hope Network’s Talking About Clinical Trials (TACT) program.
February 2024 Newsletter
Lazarex Cancer Foundation update from our founder, Dana Dornsife, 7th annual 5.44K registration open, hear from Lazarex VIP Tiffany Collins, children’s book Willis Watson is a Wannabe hits bookstores on February 27, So CA Lazarex Cancer Wellness HUB in the community update…
< Timeline >
December 12, 2023
McKinney man helped by cancer non-profit hopes to encourage other People of Color: When Vernell Brown of McKinney found out he had cancer, the 62-year-old nurse became a patient and kept his diagnosis a secret from his family for months. With Vernell Brown (Lazarex patient) and Dana Dornsife, Lazarex founder.
September 28, 2023
Lazarex Cancer Foundation Founder Receives Champion for Cures Award From Leaders of 100+ Cancer Centers. The Association of American Cancer Institutes (AACI) has chosen Dana Dornsife, founder and Chief Mission and Strategy Officer of Lazarex Cancer Foundation, to receive its distinguished 2023 Champion for Cures Award.
June 19, 2023
On June 6, 2023, Disrupting the System VI was held on Capitol Hill in Washington, D.C., marking 6 years of hosting provocative conversations to drive equity, improve access and promote change to cancer care. This year’s focus was identifying practical ways to level the playing field when it comes to cancer health disparities, patient access and outcomes – with a focus on genomic testing and health insurance. Read the summary…
May 2, 2023
New Georgia law will reimburse cancer patients for their participation in trials: Governor Brian Kemp signed SB223 into law Tuesday. The legislation, now paves the way for trial sponsors, like hospitals, pharmaceutical companies, and non-profits, to reimburse cancer patients for the costs they incur by participating in trials.
March 30, 2023
Lazarex Cancer Foundation Receives the Inaugural Glen De Vries Epic Award commemorating Medidata’s co-founder, who inspired others to create transformational change:
Lazarex Cancer Foundation focuses on improving cancer health outcomes, cancer clinical trial diversity and enrollment, and patient access to care. “I love what Glen has created in Medidata and I am so honored to receive this award in his memory,” said Dana Dornsife, CEO and Founder of the Lazarex Cancer Foundation. “It was clear at NEXT that Medidata and its partners appreciate that patients come first, and so I want to thank Medidata for helping us help them.”
March 27, 2023
Medical Gaslighting of Women is Real and So is its Toll: It happened to Serena Williams. It recently happened to my friend Stephanie Rivera, the CEO of Lazarex Cancer Foundation. It’s also happened to me. It’s medical gaslighting — dismissing, downplaying or not believing patients when they share their symptoms in a healthcare setting. By Marya Shegog, Health Equity and Diversity Director for Lazarex Cancer Foundation.
March 23, 2023
Lazarex Cancer Foundation Among Honorees for #GameChangers Award: Eight innovative companies from California will be honored at Innovation Tri-Valley Leadership Group’s 2023 #GameChangers Awards next week. The annual awards ceremony brings together founders, mentors, stakeholders and influencers from the Bay Area for a night that honors local companies and leaders for their ground-breaking solutions to different issues in the world.
February 27, 2023
The MMRF and Lazarex Cancer Foundation Partner to Improve Equitable Access to Myeloma Clinical Trials: As part of the partnership, the MMRF contributed $100,000 to Lazarex’s PATH Program, a service designed to improve enrollment and diversity in clinical trials through patient reimbursement of out-of-pocket travel costs, community outreach, and engagement.
< Timeline >
July 27, 2022
Stephanie Rivera , CEO, Lazarex Cancer Foundation, joins Yo to discuss how the Foundation’s efforts to address the gap and barriers in accessing cancer trials for minority populations. This Foundation leads the way to improve cancer health outcomes, FDA cancer clinical trial diversity and enrollment, and..
July 17, 2022
Clayton Woman Battles Rare Cancer. Receiving a cancer diagnosis is always devastating. But for Rhonda Long of Clayton, the road just to get to a definitive diagnosis was long and difficult. Because bile duct cancer is rare, there aren’t many programs established to help patients diagnosed with it. But Lazarex Cancer Foundation offered lodging and transportation assistance when she started her second clinical trial.